HUGO ID Detailed Result 6871

PMID	Match String	Actual String	Score	Flanking text	Edited by	Edit
12060810	p38	p38	1.7	and proliferation of microglia induced by excitotoxicity by inhibiting the p38 mitogen-activated protein kinase (p38 p38 MAPK _amp_#91 6 _amp_#93
12060810	p38	p38	1.7	by excitotoxicity by inhibiting the p38 mitogen-activated protein kinase (p38 p38 MAPK _amp_#91 6 _amp_#93
12060810	MAPK	MAPK	2.0	excitotoxicity by inhibiting the p38 mitogen-activated protein kinase (p38 p38 MAPK _amp_#91 6 _amp_#93
14739060	MAP	MAP	0.3	for neurons astrocytes and microglia such as mitogene-activated protein (MAP) MAP kinase cascade activation ion transport calcium mobilization and apoptosis program
16104843	p38	p38	2.2	signalling appears to preferentially modulate the reorganization of actin via p38 MAPK (mitogen-activated mitogen-activated protein kinase whereas VEGFR-2 contributes to the
16104843	MAPK	MAPK	2.2	appears to preferentially modulate the reorganization of actin via p38 MAPK (mitogen-activated mitogen-activated protein kinase whereas VEGFR-2 contributes to the re-organization
16104843	MAPK	MAPK	2.2	(protein protein kinase C -dependent activation of p42/p44 p42 p44 MAPK 88
16104843	MAPK	MAPK	2.2	cell proliferation via the PLC-g /PKC/Raf/MEK PKC Raf MEK [MAPK/ERK MAPK ERK (extracellular-signal-regulated extracellular-signal-regulated kinase kinase]/ERK kinase ERK pathway
16104843	ERK	ERK	2.2	proliferation via the PLC-g /PKC/Raf/MEK PKC Raf MEK [MAPK/ERK MAPK ERK (extracellular-signal-regulated extracellular-signal-regulated kinase kinase]/ERK kinase ERK pathway
16104843	ERK	ERK	2.2	Raf MEK [MAPK/ERK MAPK ERK (extracellular-signal-regulated extracellular-signal-regulated kinase kinase]/ERK kinase ERK pathway
16104843	p38	p38	2.2	be required to trigger the sequential activation of Cdc42 and p38 MAPK and to drive p38 MAPK-mediated actin remodelling in stress
16104843	MAPK	MAPK	2.2	required to trigger the sequential activation of Cdc42 and p38 MAPK and to drive p38 MAPK-mediated actin remodelling in stress fibres
16104843	p38	p38	2.2	sequential activation of Cdc42 and p38 MAPK and to drive p38 MAPK-mediated actin remodelling in stress fibres in endothelial cells exposed
16104843	MAPK	MAPK-mediated	2.2	activation of Cdc42 and p38 MAPK and to drive p38 MAPK-mediated actin remodelling in stress fibres in endothelial cells exposed to
16104843	p38	p38	2.2	A recent study 126 has shown that inhibition of p38 MAPK activity abrogated VEGF-induced vascular permeability in vivo and in
16104843	MAPK	MAPK	2.2	A recent study 126 has shown that inhibition of p38 MAPK activity abrogated VEGF-induced vascular permeability in vivo and in vitro
16104843	p38	p38	2.2	permeability in vivo and in vitro suggesting the involvement of p38 MAPK in the control of vascular permeability ( Figure 2
16104843	MAPK	MAPK	2.2	in vivo and in vitro suggesting the involvement of p38 MAPK in the control of vascular permeability ( Figure 2
16104843	ERK	ERK	2.2	DSCR1 Down syndrome critical region protein 1 ECM extracellular matrix ERK extracellular signal-regulated kinase FAK focal adhesion kinase HIF-1 hypoxia-inducible factor-1
16104843	MAPK	MAPK	2.2	endothelial cell LSEC liver sinusoidal endothelial cell mAb monoclonal antibody MAPK mitogen-activated protein kinase MMP matrix metalloproteinase NFATc nuclear factor of
16647138	MAP	MAP	0.9	PAF stimulates phosphatidylinositol 3-kinase and mitogen-activated protein (MAP) MAP kinase and inhibits adenylate cyclase
17191135	ERK	ERKs	0.0	The activated forms of ERKs (extracellular extracellular signal-regulated kinases were also decreased in cells overexpressing	Junguk Hur
17191135	ERK	ERKs	0.0	overexpressing HO-1 although no changes in the expression of total ERKs were observed 93	Junguk Hur
17582695	p38	p38	1.7	The p38 mitogen-activated protein kinase (p38MAPK) p38MAPK is activated by a variety
17582695	p38	p38	1.7	Inhibition of p38 signalling activated by NO exposure in rat models of MS
17582695	p38	p38	1.7	Activation of p38 MAPK is associated with upregulation of TNF alpha receptors in
17582695	MAPK	MAPK	1.7	Activation of p38 MAPK is associated with upregulation of TNF alpha receptors in the
17582695	p38	p38	1.7	Importantly p38 MAPK pathway is selectively inhibited by PACAP in hypoxic activation
17582695	MAPK	MAPK	1.7	Importantly p38 MAPK pathway is selectively inhibited by PACAP in hypoxic activation of
17997855	p38	p38	0.5	The massive Ca 2 influx causes activation of p38 MAPK opening of the mitochondrial permeability transition (MPT) MPT pore
17997855	MAPK	MAPK	0.5	The massive Ca 2 influx causes activation of p38 MAPK opening of the mitochondrial permeability transition (MPT) MPT pore and
18312546	p38	p38	1.7	Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a
18312546	MAP	MAP	1.7	Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic
18312546	p38	p38	1.7	immunohistochemical and immunoblot analyses of PPARgamma active form of phosphorylated p38 mitogen-activated protein kinase (p-p38) p-p38 and inhibitor of nuclear factor-kappaB
18312546	p38	p38-mediated	1.7	Our results suggest that pioglitazone protects motor neurons against p38-mediated neuronal death and NF-kappaB-mediated glial inflammation via a PPARgamma-independent mechanism
18464925	MAP	MAP	2.2	colleagues 61 showed that ciglitazone and 15d-PGJ 2 activated the MAP kinase cascades (Erk, Erk Jnk and p38 MAP kinase in
18464925	p38	p38	2.2	2 activated the MAP kinase cascades (Erk, Erk Jnk and p38 MAP kinase in astrocytes by a PPAR-_amp_#x003b3 independent mechanism which
18464925	MAP	MAP	2.2	activated the MAP kinase cascades (Erk, Erk Jnk and p38 MAP kinase in astrocytes by a PPAR-_amp_#x003b3 independent mechanism which required